Global Medical Antifungal Agent Market Size, Share, Trends and Forecast 2022-2030

Market Analysis and Insights: Global Medical Antifungal Agent Market
Antifungals are medicines that kill or stop the growth of fungi that cause infections.

Due to the COVID-19 pandemic, the global Medical Antifungal Agent market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Azoles accounting for % of the Medical Antifungal Agent global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Dermatophytosis segment is altered to an % CAGR throughout this forecast period.

China Medical Antifungal Agent market size is valued at US$ million in 2021, while the US and Europe Medical Antifungal Agent are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Medical Antifungal Agent landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

The global key manufacturers of Medical Antifungal Agent include Novartis, Pfizer, Bayer, Sanofi, Merck & Co, GlaxoSmithKline, MSD Manuals, Abbott and Glenmark, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Azoles

Echinocandins

Polyenes

Allylamines

Others

Segment by Application

Dermatophytosis

Aspergillosis

Candidiasis

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Medical Antifungal Agent market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Novartis

Pfizer

Bayer

Sanofi

Merck & Co

GlaxoSmithKline

MSD Manuals

Abbott

Glenmark

Enzon Pharmaceuticals

Astellas Pharma

Scynexis

Cidara Therapeutics

Lucigen Corporation

Biosergen

F2G

Sichuan Meidakang Pharmaceutical

Chengdu Taihe Health Technology

1 Study Coverage
1.1 Medical Antifungal Agent Product Introduction

1.2 Market by Type

1.2.1 Global Medical Antifungal Agent Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Azoles

1.2.3 Echinocandins

1.2.4 Polyenes

1.2.5 Allylamines

1.2.6 Others

1.3 Market by Application

1.3.1 Global Medical Antifungal Agent Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Dermatophytosis

1.3.3 Aspergillosis

1.3.4 Candidiasis

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Medical Antifungal Agent Sales Estimates and Forecasts 2017-2028

2.2 Global Medical Antifungal Agent Revenue Estimates and Forecasts 2017-2028

2.3 Global Medical Antifungal Agent Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Medical Antifungal Agent Sales by Region

2.4.1 Global Medical Antifungal Agent Sales by Region (2017-2022)

2.4.2 Global Sales Medical Antifungal Agent by Region (2023-2028)

2.5 Global Medical Antifungal Agent Revenue by Region

2.5.1 Global Medical Antifungal Agent Revenue by Region (2017-2022)

2.5.2 Global Medical Antifungal Agent Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Medical Antifungal Agent Sales by Manufacturers

3.1.1 Global Top Medical Antifungal Agent Manufacturers by Sales (2017-2022)

3.1.2 Global Medical Antifungal Agent Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Antifungal Agent in 2021

3.2 Global Medical Antifungal Agent Revenue by Manufacturers

3.2.1 Global Medical Antifungal Agent Revenue by Manufacturers (2017-2022)

3.2.2 Global Medical Antifungal Agent Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Medical Antifungal Agent Revenue in 2021

3.3 Global Medical Antifungal Agent Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Medical Antifungal Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Medical Antifungal Agent Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Medical Antifungal Agent Sales by Type

4.1.1 Global Medical Antifungal Agent Historical Sales by Type (2017-2022)

4.1.2 Global Medical Antifungal Agent Forecasted Sales by Type (2023-2028)

4.1.3 Global Medical Antifungal Agent Sales Market Share by Type (2017-2028)

4.2 Global Medical Antifungal Agent Revenue by Type

4.2.1 Global Medical Antifungal Agent Historical Revenue by Type (2017-2022)

4.2.2 Global Medical Antifungal Agent Forecasted Revenue by Type (2023-2028)

4.2.3 Global Medical Antifungal Agent Revenue Market Share by Type (2017-2028)

4.3 Global Medical Antifungal Agent Price by Type

4.3.1 Global Medical Antifungal Agent Price by Type (2017-2022)

4.3.2 Global Medical Antifungal Agent Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Medical Antifungal Agent Sales by Application

5.1.1 Global Medical Antifungal Agent Historical Sales by Application (2017-2022)

5.1.2 Global Medical Antifungal Agent Forecasted Sales by Application (2023-2028)

5.1.3 Global Medical Antifungal Agent Sales Market Share by Application (2017-2028)

5.2 Global Medical Antifungal Agent Revenue by Application

5.2.1 Global Medical Antifungal Agent Historical Revenue by Application (2017-2022)

5.2.2 Global Medical Antifungal Agent Forecasted Revenue by Application (2023-2028)

5.2.3 Global Medical Antifungal Agent Revenue Market Share by Application (2017-2028)

5.3 Global Medical Antifungal Agent Price by Application

5.3.1 Global Medical Antifungal Agent Price by Application (2017-2022)

5.3.2 Global Medical Antifungal Agent Price Forecast by Application (2023-2028)

6 North America

6.1 North America Medical Antifungal Agent Market Size by Type

6.1.1 North America Medical Antifungal Agent Sales by Type (2017-2028)

6.1.2 North America Medical Antifungal Agent Revenue by Type (2017-2028)

6.2 North America Medical Antifungal Agent Market Size by Application

6.2.1 North America Medical Antifungal Agent Sales by Application (2017-2028)

6.2.2 North America Medical Antifungal Agent Revenue by Application (2017-2028)

6.3 North America Medical Antifungal Agent Market Size by Country

6.3.1 North America Medical Antifungal Agent Sales by Country (2017-2028)

6.3.2 North America Medical Antifungal Agent Revenue by Country (2017-2028)

6.3.3 United States

6.3.4 Canada

7 Europe

7.1 Europe Medical Antifungal Agent Market Size by Type

7.1.1 Europe Medical Antifungal Agent Sales by Type (2017-2028)

7.1.2 Europe Medical Antifungal Agent Revenue by Type (2017-2028)

7.2 Europe Medical Antifungal Agent Market Size by Application

7.2.1 Europe Medical Antifungal Agent Sales by Application (2017-2028)

7.2.2 Europe Medical Antifungal Agent Revenue by Application (2017-2028)

7.3 Europe Medical Antifungal Agent Market Size by Country

7.3.1 Europe Medical Antifungal Agent Sales by Country (2017-2028)

7.3.2 Europe Medical Antifungal Agent Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Medical Antifungal Agent Market Size by Type

8.1.1 Asia Pacific Medical Antifungal Agent Sales by Type (2017-2028)

8.1.2 Asia Pacific Medical Antifungal Agent Revenue by Type (2017-2028)

8.2 Asia Pacific Medical Antifungal Agent Market Size by Application

8.2.1 Asia Pacific Medical Antifungal Agent Sales by Application (2017-2028)

8.2.2 Asia Pacific Medical Antifungal Agent Revenue by Application (2017-2028)

8.3 Asia Pacific Medical Antifungal Agent Market Size by Region

8.3.1 Asia Pacific Medical Antifungal Agent Sales by Region (2017-2028)

8.3.2 Asia Pacific Medical Antifungal Agent Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Medical Antifungal Agent Market Size by Type

9.1.1 Latin America Medical Antifungal Agent Sales by Type (2017-2028)

9.1.2 Latin America Medical Antifungal Agent Revenue by Type (2017-2028)

9.2 Latin America Medical Antifungal Agent Market Size by Application

9.2.1 Latin America Medical Antifungal Agent Sales by Application (2017-2028)

9.2.2 Latin America Medical Antifungal Agent Revenue by Application (2017-2028)

9.3 Latin America Medical Antifungal Agent Market Size by Country

9.3.1 Latin America Medical Antifungal Agent Sales by Country (2017-2028)

9.3.2 Latin America Medical Antifungal Agent Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

9.3.6 Colombia

10 Middle East and Africa

10.1 Middle East and Africa Medical Antifungal Agent Market Size by Type

10.1.1 Middle East and Africa Medical Antifungal Agent Sales by Type (2017-2028)

10.1.2 Middle East and Africa Medical Antifungal Agent Revenue by Type (2017-2028)

10.2 Middle East and Africa Medical Antifungal Agent Market Size by Application

10.2.1 Middle East and Africa Medical Antifungal Agent Sales by Application (2017-2028)

10.2.2 Middle East and Africa Medical Antifungal Agent Revenue by Application (2017-2028)

10.3 Middle East and Africa Medical Antifungal Agent Market Size by Country

10.3.1 Middle East and Africa Medical Antifungal Agent Sales by Country (2017-2028)

10.3.2 Middle East and Africa Medical Antifungal Agent Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Novartis

11.1.1 Novartis Corporation Information

11.1.2 Novartis Overview

11.1.3 Novartis Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Novartis Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Novartis Recent Developments

11.2 Pfizer

11.2.1 Pfizer Corporation Information

11.2.2 Pfizer Overview

11.2.3 Pfizer Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Pfizer Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Pfizer Recent Developments

11.3 Bayer

11.3.1 Bayer Corporation Information

11.3.2 Bayer Overview

11.3.3 Bayer Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Bayer Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Bayer Recent Developments

11.4 Sanofi

11.4.1 Sanofi Corporation Information

11.4.2 Sanofi Overview

11.4.3 Sanofi Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Sanofi Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Sanofi Recent Developments

11.5 Merck & Co

11.5.1 Merck & Co Corporation Information

11.5.2 Merck & Co Overview

11.5.3 Merck & Co Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Merck & Co Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Merck & Co Recent Developments

11.6 GlaxoSmithKline

11.6.1 GlaxoSmithKline Corporation Information

11.6.2 GlaxoSmithKline Overview

11.6.3 GlaxoSmithKline Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 GlaxoSmithKline Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 GlaxoSmithKline Recent Developments

11.7 MSD Manuals

11.7.1 MSD Manuals Corporation Information

11.7.2 MSD Manuals Overview

11.7.3 MSD Manuals Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 MSD Manuals Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 MSD Manuals Recent Developments

11.8 Abbott

11.8.1 Abbott Corporation Information

11.8.2 Abbott Overview

11.8.3 Abbott Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Abbott Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Abbott Recent Developments

11.9 Glenmark

11.9.1 Glenmark Corporation Information

11.9.2 Glenmark Overview

11.9.3 Glenmark Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Glenmark Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Glenmark Recent Developments

11.10 Enzon Pharmaceuticals

11.10.1 Enzon Pharmaceuticals Corporation Information

11.10.2 Enzon Pharmaceuticals Overview

11.10.3 Enzon Pharmaceuticals Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Enzon Pharmaceuticals Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Enzon Pharmaceuticals Recent Developments

11.11 Astellas Pharma

11.11.1 Astellas Pharma Corporation Information

11.11.2 Astellas Pharma Overview

11.11.3 Astellas Pharma Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 Astellas Pharma Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Astellas Pharma Recent Developments

11.12 Scynexis

11.12.1 Scynexis Corporation Information

11.12.2 Scynexis Overview

11.12.3 Scynexis Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.12.4 Scynexis Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Scynexis Recent Developments

11.13 Cidara Therapeutics

11.13.1 Cidara Therapeutics Corporation Information

11.13.2 Cidara Therapeutics Overview

11.13.3 Cidara Therapeutics Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.13.4 Cidara Therapeutics Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Cidara Therapeutics Recent Developments

11.14 Lucigen Corporation

11.14.1 Lucigen Corporation Corporation Information

11.14.2 Lucigen Corporation Overview

11.14.3 Lucigen Corporation Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.14.4 Lucigen Corporation Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 Lucigen Corporation Recent Developments

11.15 Biosergen

11.15.1 Biosergen Corporation Information

11.15.2 Biosergen Overview

11.15.3 Biosergen Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.15.4 Biosergen Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 Biosergen Recent Developments

11.16 F2G

11.16.1 F2G Corporation Information

11.16.2 F2G Overview

11.16.3 F2G Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.16.4 F2G Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.16.5 F2G Recent Developments

11.17 Sichuan Meidakang Pharmaceutical

11.17.1 Sichuan Meidakang Pharmaceutical Corporation Information

11.17.2 Sichuan Meidakang Pharmaceutical Overview

11.17.3 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.17.4 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.17.5 Sichuan Meidakang Pharmaceutical Recent Developments

11.18 Chengdu Taihe Health Technology

11.18.1 Chengdu Taihe Health Technology Corporation Information

11.18.2 Chengdu Taihe Health Technology Overview

11.18.3 Chengdu Taihe Health Technology Medical Antifungal Agent Sales, Price, Revenue and Gross Margin (2017-2022)

11.18.4 Chengdu Taihe Health Technology Medical Antifungal Agent Product Model Numbers, Pictures, Descriptions and Specifications

11.18.5 Chengdu Taihe Health Technology Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Medical Antifungal Agent Industry Chain Analysis

12.2 Medical Antifungal Agent Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Medical Antifungal Agent Production Mode & Process

12.4 Medical Antifungal Agent Sales and Marketing

12.4.1 Medical Antifungal Agent Sales Channels

12.4.2 Medical Antifungal Agent Distributors

12.5 Medical Antifungal Agent Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Medical Antifungal Agent Industry Trends

13.2 Medical Antifungal Agent Market Drivers

13.3 Medical Antifungal Agent Market Challenges

13.4 Medical Antifungal Agent Market Restraints

14 Key Findings in The Global Medical Antifungal Agent Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer